Adage Capital Partners’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $69.2M | Buy |
|
|||||
|
2025
Q2 | $50.2M | Buy |
|
|||||
|
2025
Q1 | $58.8M | Buy |
|
|||||
|
2024
Q4 | $31.6M | Sell |
|
|||||
|
2024
Q3 | $178M | Buy |
|
|||||
|
2024
Q2 | $171M | Buy |
|
|||||
|
2024
Q1 | $127M | Sell |
|
|||||
|
2023
Q4 | $119M | Buy |
|
|||||
|
2023
Q3 | $78M | Sell |
|
|||||
|
2023
Q2 | $99.2M | Sell |
|
|||||
|
2023
Q1 | $142M | Buy |
|
|||||
|
2022
Q4 | $52.2M | Buy |
|
|||||
|
2022
Q3 | $42.9M | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $66M | Sell |
|
|||||
|
2021
Q4 | $60.4M | Buy |
|
|||||
|
2021
Q3 | $57.8M | Sell |
|
|||||
|
2021
Q2 | $54M | Buy |
|
|||||
|
2021
Q1 | $22.9M | Sell |
|
|||||
|
2020
Q4 | $48.6M | Sell |
|
|||||
|
2020
Q3 | $57M | Sell |
|
|||||
|
2020
Q2 | $94.1M | Buy |
|
|||||
|
2020
Q1 | $32.3M | Buy |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $13.8M | Sell |
|
|||||
|
2018
Q3 | $36M | Buy |
|
|||||
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $5.33M | Sell |
|
|||||
|
2017
Q2 | $28.5M | Buy |
|
|||||
|
2017
Q1 | – | Sell |
|
|||||
|
2016
Q4 | $4.89M | Sell |
|
|||||
|
2016
Q3 | $48.4M | Buy |
|
|||||
|
2016
Q2 | $15.8M | Sell |
|
|||||
|
2016
Q1 | $18.5M | Sell |
|
|||||
|
2015
Q4 | $63.1M | Buy |
|
|||||
|
2015
Q3 | $52.8M | Buy |
|
|||||
|
2015
Q2 | $33.1M | Buy |
|
|||||
|
2015
Q1 | $21.2M | Sell |
|
|||||
|
2014
Q4 | $29.5M | Buy |
|
|||||
|
2014
Q3 | $16.1M | Sell |
|
|||||
|
2014
Q2 | $67.5M | Sell |
|
|||||
|
2014
Q1 | $90.9M | Buy |
|
|||||
|
2013
Q4 | $33.3M | Sell |
|
|||||
|
2013
Q3 | $96.9M | Buy |
|
|||||
|
2013
Q2 | $66.3M | Buy |
|